Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Works matching IS 17762596 AND DT 2009 AND VI 4 AND IP 2
Results: 10
1
2
The toxicities of modern targeted therapies: learning from the price of progress.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
3
Indexing: the north face.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
4
The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents.
- Published in:
- 2009
- By:
- Publication type:
- journal article
5
Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
6
Maximum tolerated dose: clinical endpoint for a bygone era?
- Published in:
- 2009
- By:
- Publication type:
- journal article
7
Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?
- Published in:
- 2009
- By:
- Publication type:
- journal article
8
QT interval prolongation among patients treated with angiogenesis inhibitors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
9
Renal toxicity of targeted therapies.
- Published in:
- 2009
- By:
- Publication type:
- journal article
10
Skin toxicities associated with epidermal growth factor receptor inhibitors.
- Published in:
- 2009
- By:
- Publication type:
- journal article